✦ LIBER ✦

ANTIPLATELET DRUGS IN THE SECONDARY PREVENTION OF MYOCARDIAL INFARCTION

✍ Scribed by Mcnicol, GeorgeP

Book ID: 123160166
Publisher: The Lancet
Year: 1980
Tongue: English
Weight: 454 KB
Volume: 316
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(80)91950-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma drug and antiplatelet profiles of

Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction

✍ R. Simrock; K. Rehders; H. Spahn; E. Mutschler; H. K. Breddin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 926 KB

SECONDARY PREVENTION AFTER MYOCARDIAL IN

SECONDARY PREVENTION AFTER MYOCARDIAL INFARCTION

✍ Evans, AlunE 📂 Article 📅 1986 🏛 The Lancet 🌐 English ⚖ 330 KB

Secondary prevention after myocardial in

Secondary prevention after myocardial infarction with class III antiarrhythmic drugs

✍ Leszek Ceremużyński 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Secondary prevention in myocardial infar

Secondary prevention in myocardial infarction survivors

✍ G. Schettler; G. Rose; K. König 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Which drugs benefit diabetic patients fo

Which drugs benefit diabetic patients for secondary prevention of myocardial infarction?

✍ MacDonald, T.M.; Butler, R.; Newton, R.W.; Morris, A.D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Diabetic patients have increased mortality following myocardial infarction. We review the evidence for benefit in diabetic patients, of the major drug groups used as secondary prevention. Beta blockers: meta-analyses suggest a reduction in mortality of 35 % with beta blockers. Diabetic patients shou

Antithrombotic therapy in the secondary

Antithrombotic therapy in the secondary prevention of myocardial infarction

✍ Colin R.M. Prentice 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 733 KB